HTG MOLECULAR DIAGNOSTICS IN's ticker is HTGM and the CUSIP is 40434H104. A total of 40 filers reported holding HTG MOLECULAR DIAGNOSTICS IN in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $1,336,000 | -34.9% | 804,964 | -2.0% | 0.07% | -40.0% |
| Q1 2019 | $2,053,000 | -12.6% | 821,116 | -11.2% | 0.11% | -33.7% |
| Q4 2018 | $2,348,000 | -50.6% | 924,300 | -1.8% | 0.17% | -35.7% |
| Q3 2018 | $4,753,000 | +59.3% | 941,170 | +2.8% | 0.26% | +43.3% |
| Q2 2018 | $2,984,000 | +2.7% | 915,449 | +14.1% | 0.18% | -14.3% |
| Q1 2018 | $2,905,000 | +199.8% | 802,521 | +68.1% | 0.21% | +176.3% |
| Q4 2017 | $969,000 | +36.9% | 477,438 | +14.6% | 0.08% | +28.8% |
| Q3 2017 | $708,000 | +276.6% | 416,608 | +488.3% | 0.06% | +247.1% |
| Q2 2017 | $188,000 | -17.5% | 70,810 | +114.5% | 0.02% | -26.1% |
| Q1 2017 | $228,000 | – | 33,010 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Novo Holdings A/S | 1,280,185 | $9,755,000 | 1.01% |
| Cormorant Asset Management, LP | 201,000 | $1,532,000 | 0.24% |
| PUTNAM INVESTMENTS LLC | 575,692 | $4,386,000 | 0.01% |
| Alyeska Investment Group, L.P. | 114,113 | $870,000 | 0.01% |
| VANGUARD GROUP INC | 4,355,424 | $131,473,000 | 0.01% |
| BLACKROCK ADVISORS LLC | 463,200 | $3,530,000 | 0.00% |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 26,100 | $199,000,000 | 0.00% |
| Ironwood Financial, llc | 870 | $7,000 | 0.00% |
| PANAGORA ASSET MANAGEMENT INC | 24,293 | $185,000 | 0.00% |
| Sonora Investment Management, LLC | 500 | $3,000 | 0.00% |